🇬🇧 Bay Ntn 33893 in United Kingdom

Bay Ntn 33893 (imidacloprid) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Status: likely_approved

Bay Ntn 33893 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United Kingdom

Frequently asked questions

Is Bay Ntn 33893 approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for Bay Ntn 33893 in United Kingdom?

Marketing authorisation holder not available in our data.